C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61P 25/00 (2006.01) A61P 31/18 (2006.01) C07D 519/00 (2006.01)
Patent
CA 2603876
Compounds represented by Formula (I): and/or pharmaceutically acceptable salts, individual enantiomers and stereoisomers thereof, are effective as NMDA/NR2B antagonists useful for treating conditions such as pain, Parkinson~s disease, Alzheimer~s disease, epilepsy, depression, anxiety, ischemic brain injury including stroke.
La présente invention concerne des composés représentés par la formule (I) et/ou des sels, des énantiomères individuels et des stéréoisomères de ceux-ci, acceptables d'un point de vue pharmaceutique, qui sont efficaces comme antagonistes de NMDA/NR2B, utilisés pour traiter des pathologies comme la douleur, la maladie de Parkinson, la maladie d'Alzheimer, l'épilepsie, la dépression, l'anxiété et les lésions cérébrales d'origine ischémique, par exemple l'accident vasculaire cérébral.
Kelly Michael J. III
Layton Mark E.
Rodzinak Kevin J.
Sanderson Philip E.
Merck & Co. Inc.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
N-alkyl-azacycloalkyl nmda/nr2b antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-alkyl-azacycloalkyl nmda/nr2b antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-alkyl-azacycloalkyl nmda/nr2b antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1806057